{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:05:12Z","timestamp":1789668312471,"version":"4.0.1"},"reference-count":158,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Colorado Office of Economic Development"},{"name":"International Trade Advanced Industries Grant Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Genetic engineering can transform bacteria (including Salmonella, Escherichia coli, Listeria, and Yersinia) from naturally occurring microbes into programmable therapeutics. Unlike passive platforms, engineered bacteria can localize to defined biological niches, sense environmental cues, regulate programmed activity in situ, interact with host tissues in novel ways, and persist for controlled periods. These properties make bacteria versatile medicines but require genetic control of precision, safety, stability, and activity under clinical conditions. Major design layers include strain or \u201cchassis\u201d selection, attenuation and biocontainment, control of therapeutic activity, targeting and persistence, and genotype-to-phenotype stability during manufacturing and in vivo use. These features also create liabilities, including off-target behavior, unstable expression, and evolutionary loss of function under selection. Progress depends on safe, clinically translatable chassis with integrated, bounded, and durable behaviors. This review examines the genetic design principles and liabilities of bacteria-based therapeutics, approaches used to produce clinical and near-clinical candidates, and the emergence of programmed bacteria delivering complete gene editing systems to therapeutically relevant cells.<\/jats:p>","DOI":"10.1093\/genetics\/iyag235","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:28:19Z","timestamp":1789666099000},"source":"Crossref","is-referenced-by-count":0,"title":["Genetic principles enabling the creation of bacteria-based therapeutics"],"prefix":"10.1093","author":[{"given":"Ashley B","family":"Williams","sequence":"first","affiliation":[{"name":"SiVEC Biotechnologies, Inc , 3185 Rampart Road, Fort Collins, CO 80521 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7831-4294","authenticated-orcid":false,"given":"Thomas M","family":"Groseclose","sequence":"additional","affiliation":[{"name":"SiVEC Biotechnologies, Inc , 3185 Rampart Road, Fort Collins, CO 80521 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A M","family":"Holec","sequence":"additional","affiliation":[{"name":"SiVEC Biotechnologies, Inc , 3185 Rampart Road, Fort Collins, CO 80521 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrian","family":"Newman","sequence":"additional","affiliation":[{"name":"SiVEC Biotechnologies, Inc , 3185 Rampart Road, Fort Collins, CO 80521 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcy S O","family":"Mora","sequence":"additional","affiliation":[{"name":"SiVEC Biotechnologies, Inc , 3185 Rampart Road, Fort Collins, CO 80521 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsey","family":"Linke","sequence":"additional","affiliation":[{"name":"SiVEC Biotechnologies, Inc , 3185 Rampart Road, Fort Collins, CO 80521 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"2026091713281185400_iyag235-B1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41571-025-01018-w","article-title":"FDA approvals in 2024: new options for patients across cancer types and therapeutic classes","volume":"22","author":"Agrawal","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"2026091713281185400_iyag235-B2","doi-asserted-by":"publisher","first-page":"101580","DOI":"10.1016\/j.omtm.2025.101580","article-title":"Landscape of ex vivo gene therapies: technological trends and future prospects","volume":"33","author":"Almeida-Oliveira","year":"2025","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2026091713281185400_iyag235-B3","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.3293","article-title":"Analysis of RecA-independent recombination events between short direct repeats related to a genomic island and to a plasmid in Escherichia coli K12","volume":"5","author":"Azpiroz","year":"2017","journal-title":"PeerJ"},{"key":"2026091713281185400_iyag235-B4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.15283\/ijsc25028","article-title":"Advances in cell and gene therapy for rare disease treatment","volume":"18","author":"Baek","year":"2025","journal-title":"Int J Stem Cells"},{"key":"2026091713281185400_iyag235-B5","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20160616","article-title":"Cytoplasmic transport and nuclear import of plasmid DNA","volume":"37","author":"Bai","year":"2017","journal-title":"Biosci Rep"},{"key":"2026091713281185400_iyag235-B6","doi-asserted-by":"publisher","first-page":"114167","DOI":"10.1016\/j.jconrel.2025.114167","article-title":"Factors affecting drug delivery system translation: a focus on advanced technologies, biological barriers, and regulatory challenges","volume":"387","author":"Balash","year":"2025","journal-title":"J Control Release"},{"key":"2026091713281185400_iyag235-B7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00262-026-04307-0","article-title":"A phase 2 study of orally administered live biotherapeutic salmonella-IL2 with FOLFIRINOX for stage IV pancreatic cancer","volume":"75","author":"Batist","year":"2026","journal-title":"Cancer Immunol Immunother"},{"key":"2026091713281185400_iyag235-B8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","article-title":"Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer","volume":"21","author":"Bayne","year":"2012","journal-title":"Cancer Cell"},{"key":"2026091713281185400_iyag235-B9","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.3390\/cancers14174224","article-title":"Recombinant attenuated Salmonella enterica as a delivery system of heterologous molecules in cancer therapy","volume":"14","author":"Becerra-B\u00e1ez","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026091713281185400_iyag235-B10","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1006\/jmbi.1996.0131","article-title":"A replicational model for DNA recombination between direct repeats","volume":"256","author":"Bi","year":"1996","journal-title":"J Mol Biol"},{"key":"2026091713281185400_iyag235-B11","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1021\/acsnano.4c11858","article-title":"Emerging delivery systems for enabling precision nucleic acid therapeutics","volume":"19","author":"Bian","year":"2025","journal-title":"ACS Nano"},{"key":"2026091713281185400_iyag235-B12","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.1128\/JB.182.17.4811-4821.2000","article-title":"Competition between the Yops of Yersinia enterocolitica for delivery into eukaryotic cells: role of the SycE chaperone binding domain of YopE","volume":"182","author":"Boyd","year":"2000","journal-title":"J Bacteriol"},{"key":"2026091713281185400_iyag235-B13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jbiotec.2015.07.010","article-title":"Rescuing chemotaxis of the anticancer agent Salmonella enterica serovar Typhimurium VNP20009","volume":"211","author":"Broadway","year":"2015","journal-title":"J Biotechnol"},{"key":"2026091713281185400_iyag235-B14","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.1128\/AEM.68.11.5663-5670.2002","article-title":"Use of the alr gene as a food-grade selection marker in lactic acid bacteria","volume":"68","author":"Bron","year":"2002","journal-title":"Appl Environ Microbiol"},{"key":"2026091713281185400_iyag235-B15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nmeth.2926","article-title":"Principles of genetic circuit design","volume":"11","author":"Brophy","year":"2014","journal-title":"Nat Methods"},{"key":"2026091713281185400_iyag235-B16","first-page":"137","article-title":"Aus der Sitzung der medicinischen Section vom 13 November 1867","volume":"5","author":"Busch","year":"1868","journal-title":"Berlin Klin Wochenschr"},{"key":"2026091713281185400_iyag235-B17","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/sj.gt.3302493","article-title":"Engineered E. coli delivers therapeutic genes to the colonic mucosa","volume":"12","author":"Castagliuolo","year":"2005","journal-title":"Gene Ther"},{"key":"2026091713281185400_iyag235-B18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1146\/annurev.bi.59.070190.002551","article-title":"Self-splicing of group I introns","volume":"59","author":"Cech","year":"1990","journal-title":"Annu Rev Biochem"},{"key":"2026091713281185400_iyag235-B19","doi-asserted-by":"publisher","DOI":"10.4161\/onci.26967","article-title":"Myeloid-derived suppressor cells: cellular missiles to target tumors","volume":"2","author":"Chandra","year":"2013","journal-title":"Oncoimmunology"},{"key":"2026091713281185400_iyag235-B20","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/bjc.2013.206","article-title":"Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice","volume":"108","author":"Chandra","year":"2013","journal-title":"Br J Cancer"},{"key":"2026091713281185400_iyag235-B21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41551-021-00772-3","article-title":"Enhancing the tropism of bacteria via genetically programmed biosensors","volume":"6","author":"Chien","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"2026091713281185400_iyag235-B22","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00240-24","article-title":"Recent advances in therapeutic probiotics: insights from human trials","volume":"38","author":"Cho","year":"2025","journal-title":"Clin Microbiol Rev"},{"key":"2026091713281185400_iyag235-B23","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1021\/acssynbio.7b00462","article-title":"High-level dCas9 expression induces abnormal cell morphology in Escherichia coli","volume":"7","author":"Cho","year":"2018","journal-title":"ACS Synth Biol"},{"key":"2026091713281185400_iyag235-B24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/cpt.2996","article-title":"Novel therapeutic modalities: the future is now","volume":"114","author":"Choi","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"2026091713281185400_iyag235-B25","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1086\/315497","article-title":"Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium","volume":"181","author":"Clairmont","year":"2000","journal-title":"J Infect Dis"},{"key":"2026091713281185400_iyag235-B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/EDBK_325885","article-title":"Taking aim at the Undruggable","volume":"41","author":"Coleman","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2026091713281185400_iyag235-B27","first-page":"1207","article-title":"Gene transfer from bacteria to mammalian cells","volume":"318","author":"Courvalin","year":"1995","journal-title":"C R Acad Sci III"},{"key":"2026091713281185400_iyag235-B28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.18632\/oncotarget.28769","article-title":"ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15\/IL-15R\u03b1 and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response","volume":"16","author":"Cron","year":"2025","journal-title":"Oncotarget"},{"key":"2026091713281185400_iyag235-B29","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1093\/nar\/gkw223","article-title":"Consequences of Cas9 cleavage in the chromosome of Escherichia coli","volume":"44","author":"Cui","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2026091713281185400_iyag235-B30","first-page":"1594","article-title":"A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001","volume":"12","author":"Cunningham","year":"2001","journal-title":"Hum Gene Ther"},{"key":"2026091713281185400_iyag235-B31","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.isci.2019.01.030","article-title":"Lactococcus lactis subsp. cremoris is an efficacious beneficial bacterium that limits tissue injury in the intestine","volume":"12","author":"Darby","year":"2019","journal-title":"iScience"},{"key":"2026091713281185400_iyag235-B32","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.1073\/pnas.120163297","article-title":"One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products","volume":"97","author":"Datsenko","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026091713281185400_iyag235-B33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fcimb.2018.00261","article-title":"All Yersinia are not created equal: phenotypic adaptation to distinct niches within mammalian tissues","volume":"8","author":"Davis","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"2026091713281185400_iyag235-B34","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.14309\/00000434-201710001-00297","article-title":"Preclinical and clinical studies on safety of CEQ508 bacteria engineered to deliver short-hairpin RNA to mediate RNA interference against \u03b2-catenin in the GI tract of patients with familial adenomatous polyposis","volume":"112","author":"D\u2019Cruz","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"2026091713281185400_iyag235-B35","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.tibtech.2024.06.011","article-title":"Engineered bacterial therapeutics with material solutions","volume":"42","author":"Dey","year":"2024","journal-title":"Trends Biotechnol"},{"key":"2026091713281185400_iyag235-B36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nature18930","article-title":"Synchronized cycles of bacterial lysis for in vivo delivery","volume":"536","author":"Din","year":"2016","journal-title":"Nature"},{"key":"2026091713281185400_iyag235-B37","doi-asserted-by":"publisher","first-page":"1274210","DOI":"10.3389\/fbioe.2023.1274210","article-title":"Editorial: delivery systems in biologics-based therapeutics","volume":"11","author":"Dirisala","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"2026091713281185400_iyag235-B38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-025-00654-x","article-title":"Listeriosis","volume":"11","author":"Disson","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"2026091713281185400_iyag235-B39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","article-title":"The promise and challenge of therapeutic genome editing","volume":"578","author":"Doudna","year":"2020","journal-title":"Nature"},{"key":"2026091713281185400_iyag235-B40","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1073\/pnas.1916676117","article-title":"Listeria monocytogenes exploits host exocytosis to promote cell-to-cell spread","volume":"117","author":"Dowd","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026091713281185400_iyag235-B41","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1128\/iai.63.11.4268-4276.1995","article-title":"Listeria monocytogenes infects human endothelial cells by two distinct mechanisms","volume":"63","author":"Drevets","year":"1995","journal-title":"Infect Immun"},{"key":"2026091713281185400_iyag235-B42","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jconrel.2004.03.025","article-title":"Recombinant Escherichia coli as a gene delivery vector into airway epithelial cells","volume":"97","author":"Fajac","year":"2004","journal-title":"J Control Release"},{"key":"2026091713281185400_iyag235-B43","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40425-018-0381-3","article-title":"White paper on microbial anti-cancer therapy and prevention","volume":"6","author":"Forbes","year":"2018","journal-title":"J Immunother Cancer"},{"key":"2026091713281185400_iyag235-B44","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1146\/annurev.mi.47.100193.002343","article-title":"Adaptive mutation: the uses of adversity","volume":"47","author":"Foster","year":"1993","journal-title":"Annu Rev Microbiol"},{"key":"2026091713281185400_iyag235-B45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/b12440","article-title":"Plasmid copy number and plasmid stability","volume":"86","author":"Friehs","year":"2004","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"2026091713281185400_iyag235-B46","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1128\/jb.176.2.269-275.1994","article-title":"Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators","volume":"176","author":"Fuqua","year":"1994","journal-title":"J Bacteriol"},{"key":"2026091713281185400_iyag235-B47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1021\/cr100109t","article-title":"Quorum sensing in gram-negative bacteria: small-molecule modulation of AHL and AI-2 quorum sensing pathways","volume":"111","author":"Galloway","year":"2011","journal-title":"Chem Rev"},{"key":"2026091713281185400_iyag235-B48","doi-asserted-by":"publisher","first-page":"10542","DOI":"10.3390\/ijms262110542","article-title":"IRES-Mediated Translation: expanding the toolkits of RNA therapy","volume":"26","author":"Gao","year":"2025","journal-title":"Int J Mol Sci"},{"key":"2026091713281185400_iyag235-B49","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/cancers12020438","article-title":"Targeting melanoma hypoxia with the food-grade lactic acid bacterium Lactococcus lactis","volume":"12","author":"Garza-Morales","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026091713281185400_iyag235-B50","doi-asserted-by":"publisher","first-page":"105834","DOI":"10.1016\/j.ebiom.2025.105834","article-title":"Viral and non-viral vectors in gene therapy: current state and clinical perspectives","volume":"118","author":"Geng","year":"2025","journal-title":"EBioMedicine"},{"key":"2026091713281185400_iyag235-B51","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.resmic.2003.08.005","article-title":"The csgD promoter, a control unit for biofilm formation in Salmonella typhimurium","volume":"154","author":"Gerstel","year":"2003","journal-title":"Res Microbiol"},{"key":"2026091713281185400_iyag235-B52","doi-asserted-by":"publisher","DOI":"10.4161\/2162402X.2014.988463","article-title":"Targeting STING pathways for the treatment of cancer","volume":"4","author":"Gravekamp","year":"2015","journal-title":"Oncoimmunology"},{"key":"2026091713281185400_iyag235-B53","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nbt0998-862","article-title":"Functional gene transfer from intracellular bacteria to mammalian cells","volume":"16","author":"Grillot-Courvalin","year":"1998","journal-title":"Nat Biotechnol"},{"key":"2026091713281185400_iyag235-B54","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-biophys-090820-101708","article-title":"Biomolecular systems engineering: unlocking the potential of engineered allostery via the lactose repressor topology","volume":"50","author":"Groseclose","year":"2021","journal-title":"Annu Rev Biophys"},{"key":"2026091713281185400_iyag235-B55","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.4049\/jimmunol.167.11.6471","article-title":"Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16","volume":"167","author":"Gunn","year":"2001","journal-title":"J Immunol"},{"key":"2026091713281185400_iyag235-B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26009","article-title":"Advances in peptide-based drug delivery systems","volume":"10","author":"Guo","year":"2024","journal-title":"Heliyon"},{"key":"2026091713281185400_iyag235-B57","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/s41587-022-01244-y","article-title":"A programmable encapsulation system improves delivery of therapeutic bacteria in mice","volume":"40","author":"Harimoto","year":"2022","journal-title":"Nat Biotechnol"},{"key":"2026091713281185400_iyag235-B58","author":"Healio","year":"2015"},{"key":"2026091713281185400_iyag235-B59","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1038\/s41467-024-45045-0","article-title":"Plasmid-mediated phenotypic noise leads to transient antibiotic resistance in bacteria","volume":"15","author":"Hernandez-Beltran","year":"2024","journal-title":"Nat Commun"},{"key":"2026091713281185400_iyag235-B60","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.copbio.2011.03.009","article-title":"Tumor-seeking Salmonella amino acid auxotrophs","volume":"22","author":"Hoffman","year":"2011","journal-title":"Curr Opin Biotechnol"},{"key":"2026091713281185400_iyag235-B61","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0065-2164(10)70007-1","article-title":"Bacteriophage host range and bacterial resistance","volume":"70","author":"Hyman","year":"2010","journal-title":"Adv Appl Microbiol"},{"key":"2026091713281185400_iyag235-B62","doi-asserted-by":"publisher","first-page":"103143","DOI":"10.1016\/j.copbio.2024.103143","article-title":"Synthetic biology advances towards a bio-based society in the era of artificial intelligence","volume":"87","author":"Iram","year":"2024","journal-title":"Curr Opin Biotechnol"},{"key":"2026091713281185400_iyag235-B63","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nbt.4222","article-title":"Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria","volume":"36","author":"Isabella","year":"2018","journal-title":"Nat Biotechnol"},{"key":"2026091713281185400_iyag235-B64","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1083\/jcb.201502074","article-title":"A bacterial type III secretion-based protein delivery tool for broad applications in cell biology","volume":"211","author":"Ittig","year":"2015","journal-title":"J Cell Biol"},{"key":"2026091713281185400_iyag235-B65","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1342025","article-title":"Immunotherapy with Listeria reduces metastatic breast cancer in young and old mice through different mechanisms","volume":"6","author":"Jahangir","year":"2017","journal-title":"Oncoimmunology"},{"key":"2026091713281185400_iyag235-B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280499","article-title":"Robust performance of a live bacterial therapeutic chassis lacking the colibactin gene cluster","volume":"18","author":"Kalantari","year":"2023","journal-title":"PLoS One"},{"key":"2026091713281185400_iyag235-B67","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"2026091713281185400_iyag235-B68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264775","article-title":"Four in one-combination therapy using live Lactococcus lactis expressing three therapeutic proteins for the treatment of chronic non-healing wounds","volume":"17","author":"Kurkipuro","year":"2022","journal-title":"PLoS One"},{"key":"2026091713281185400_iyag235-B69","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/cts.12528","article-title":"Translational development of microbiome-based therapeutics: kinetics of E. coli nissle and engineered strains in humans and nonhuman primates","volume":"11","author":"Kurtz","year":"2018","journal-title":"Clin Transl Sci"},{"key":"2026091713281185400_iyag235-B70","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1093\/nar\/gkw056","article-title":"Programmable control of bacterial gene expression with the combined CRISPR and antisense RNA system","volume":"44","author":"Lee","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2026091713281185400_iyag235-B71","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.omtn.2021.03.012","article-title":"DNA nuclear targeting sequences for enhanced non-viral gene transfer: an in vitro and in vivo study","volume":"24","author":"Le Guen","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"2026091713281185400_iyag235-B72","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1021\/acschembio.4c00250","article-title":"Enhancing the anticancer activity of attenuated Listeria monocytogenes by cell wall functionalization with \u201cclickable\u201d doxorubicin","volume":"19","author":"Lepori","year":"2024","journal-title":"ACS Chem Biol"},{"key":"2026091713281185400_iyag235-B73","doi-asserted-by":"publisher","first-page":"119711","DOI":"10.1016\/j.biomaterials.2019.119711","article-title":"Ex vivo cell-based CRISPR\/Cas9 genome editing for therapeutic applications","volume":"234","author":"Li","year":"2020","journal-title":"Biomaterials"},{"key":"2026091713281185400_iyag235-B74","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.canlet.2019.01.037","article-title":"Genetically engineered Salmonella typhimurium: recent advances in cancer therapy","volume":"448","author":"Liang","year":"2019","journal-title":"Cancer Lett"},{"key":"2026091713281185400_iyag235-B75","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13568-016-0187-y","article-title":"Inhibiting avian influenza virus shedding using a novel RNAi antiviral vector technology: proof of concept in an avian cell model","volume":"6","author":"Linke","year":"2016","journal-title":"AMB Express"},{"key":"2026091713281185400_iyag235-B76","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1016\/j.ymthe.2025.03.026","article-title":"Recent advances in therapeutic gene-editing technologies","volume":"33","author":"Liu","year":"2025","journal-title":"Mol Ther"},{"key":"2026091713281185400_iyag235-B77","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202517730","article-title":"Attenuated bacteria-based tumor therapy: clinical application risks, marketing approval restrictions, and coping strategies","volume":"13","author":"Liu","year":"2026","journal-title":"Adv Sci (Weinh)"},{"key":"2026091713281185400_iyag235-B78","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/BF00290109","article-title":"Recombination between repeats in Escherichia coli by a recA-independent, proximity-sensitive mechanism","volume":"245","author":"Lovett","year":"1994","journal-title":"Mol Gen Genet"},{"key":"2026091713281185400_iyag235-B79","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/5205","article-title":"Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo","volume":"17","author":"Low","year":"1999","journal-title":"Nat Biotechnol"},{"key":"2026091713281185400_iyag235-B80","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.7150\/ijbs.83026","article-title":"Emerging pharmacotherapeutic strategies to overcome undruggable proteins in cancer","volume":"19","author":"Lu","year":"2023","journal-title":"Int J Biol Sci"},{"key":"2026091713281185400_iyag235-B81","doi-asserted-by":"publisher","DOI":"10.15252\/msb.202110539","article-title":"An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria","volume":"18","author":"Lubkowicz","year":"2022","journal-title":"Mol Syst Biol"},{"key":"2026091713281185400_iyag235-B82","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1128\/AEM.00365-13","article-title":"Comparative transcription profiling and in-depth characterization of plasmid-based and plasmid-free Escherichia coli expression systems under production conditions","volume":"79","author":"Mairhofer","year":"2013","journal-title":"Appl Environ Microbiol"},{"key":"2026091713281185400_iyag235-B83","doi-asserted-by":"publisher","first-page":"1675209","DOI":"10.3389\/fgene.2025.1675209","article-title":"Advances in RNA-based therapeutics: current breakthroughs, clinical translation, and future perspectives","volume":"16","author":"Makkar","year":"2025","journal-title":"Front Genet"},{"key":"2026091713281185400_iyag235-B84","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature14121","article-title":"Biocontainment of genetically modified organisms by synthetic protein design","volume":"518","author":"Mandell","year":"2015","journal-title":"Nature"},{"key":"2026091713281185400_iyag235-B85","doi-asserted-by":"publisher","first-page":"100549","DOI":"10.1016\/j.medj.2024.11.002","article-title":"Setting \u201ccold\u201d tumors on fire: cancer therapy with live tumor-targeting bacteria","volume":"6","author":"Manole","year":"2025","journal-title":"Med"},{"key":"2026091713281185400_iyag235-B86","first-page":"154","article-title":"The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas","volume":"26","author":"McCarthy","year":"2006","journal-title":"Iowa Orthop J"},{"key":"2026091713281185400_iyag235-B87","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/2171110a0","article-title":"DNA restriction enzyme from E. coli","volume":"217","author":"Meselson","year":"1968","journal-title":"Nature"},{"key":"2026091713281185400_iyag235-B88","doi-asserted-by":"publisher","first-page":"832395","DOI":"10.3389\/fped.2021.832395","article-title":"Editorial: new therapeutic options for rare diseases","volume":"9","author":"Meyer","year":"2021","journal-title":"Front Pediatr"},{"key":"2026091713281185400_iyag235-B89","doi-asserted-by":"publisher","DOI":"10.1002\/elsc.202200037","article-title":"An optimized live bacterial delivery vehicle safely and efficaciously delivers bacterially transcribed therapeutic nucleic acids","volume":"23","author":"Mora","year":"2023","journal-title":"Eng Life Sci"},{"key":"2026091713281185400_iyag235-B90","doi-asserted-by":"publisher","first-page":"kuad033","DOI":"10.1093\/jimb\/kuad033","article-title":"Diverse mechanisms of bioproduction heterogeneity in fermentation and their control strategies","volume":"50","author":"Mu","year":"2023","journal-title":"J Ind Microbiol Biotechnol"},{"key":"2026091713281185400_iyag235-B91","doi-asserted-by":"publisher","first-page":"102440","DOI":"10.1016\/j.omtn.2024.102440","article-title":"Nucleic acid therapeutics: past, present, and future","volume":"36","author":"Naeem","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"key":"2026091713281185400_iyag235-B92","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1128\/AEM.02667-12","article-title":"Engineering signal peptides for enhanced protein secretion from Lactococcus lactis","volume":"79","author":"Ng","year":"2013","journal-title":"Appl Environ Microbiol"},{"key":"2026091713281185400_iyag235-B93","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-60327-527-9_3","article-title":"Transkingdom RNA interference (tkRNAi): a novel method to induce therapeutic gene silencing","volume":"514","author":"Nguyen","year":"2009","journal-title":"Methods Mol Biol"},{"key":"2026091713281185400_iyag235-B94","doi-asserted-by":"publisher","first-page":"aac7341","DOI":"10.1126\/science.aac7341","article-title":"Genetic circuit design automation","volume":"352","author":"Nielsen","year":"2016","journal-title":"Science"},{"key":"2026091713281185400_iyag235-B95","doi-asserted-by":"publisher","first-page":":279","DOI":"10.1093\/procel\/pwaf085","article-title":"Engineering oncolytic bacteria as precision cancer therapeutics: design principles, therapeutic strategies, and translational perspectives","volume":"17","author":"Niu","year":"2025","journal-title":"Protein Cell"},{"key":"2026091713281185400_iyag235-B96","doi-asserted-by":"publisher","first-page":"102014","DOI":"10.1016\/j.eclinm.2023.102014","article-title":"Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial","volume":"60","author":"\u00d6hnstedt","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2026091713281185400_iyag235-B97","doi-asserted-by":"publisher","first-page":"G140","DOI":"10.1152\/ajpgi.00022.2024","article-title":"Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models","volume":"327","author":"\u00d6hnstedt","year":"2024","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2026091713281185400_iyag235-B98","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J Immunol"},{"key":"2026091713281185400_iyag235-B99","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cels.2018.06.008","article-title":"Synthetic biology and engineered live biotherapeutics: toward increasing system complexity","volume":"7","author":"Ozdemir","year":"2018","journal-title":"Cell Syst"},{"key":"2026091713281185400_iyag235-B100","doi-asserted-by":"publisher","first-page":"97","DOI":"10.38212\/2224-6614.3540","article-title":"Regulatory framework and challenges for live biotherapeutic products in Taiwan","volume":"33","author":"Pan","year":"2025","journal-title":"J Food Drug Anal"},{"key":"2026091713281185400_iyag235-B101","doi-asserted-by":"publisher","first-page":"716266","DOI":"10.3389\/fmed.2021.716266","article-title":"Entering first-in-human clinical study with a single-strain live biotherapeutic product: input and feedback gained from the EMA and the FDA","volume":"8","author":"Paquet","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2026091713281185400_iyag235-B102","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S0140-6736(23)02444-3","article-title":"mRNA-based therapeutics: looking beyond COVID-19 vaccines","volume":"403","author":"Parhiz","year":"2024","journal-title":"Lancet"},{"key":"2026091713281185400_iyag235-B103","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41568-024-00690-x","article-title":"Cancer therapy with antibodies","volume":"24","author":"Paul","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"2026091713281185400_iyag235-B104","first-page":"4537","article-title":"Tumor-targeted Salmonella as a novel anticancer vector","volume":"57","author":"Pawelek","year":"1997","journal-title":"Cancer Res"},{"key":"2026091713281185400_iyag235-B105","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.chom.2024.01.005","article-title":"The live biotherapeutic SYNB1353 decreases plasma methionine via directed degradation in animal models and healthy volunteers","volume":"32","author":"Perreault","year":"2024","journal-title":"Cell Host Microbe"},{"key":"2026091713281185400_iyag235-B106","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nchembio.2233","article-title":"Tunable thermal bioswitches for in vivo control of microbial therapeutics","volume":"13","author":"Piraner","year":"2017","journal-title":"Nat Chem Biol"},{"key":"2026091713281185400_iyag235-B107","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1093\/nar\/gkt576","article-title":"Co-expression of RNA-protein complexes in Escherichia coli and applications to RNA biology","volume":"41","author":"Ponchon","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2026091713281185400_iyag235-B108","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1093\/nar\/20.20.5357","article-title":"Group I permuted intron-exon (PIE) sequences self-splice to produce circular exons","volume":"20","author":"Puttaraju","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"2026091713281185400_iyag235-B109","doi-asserted-by":"publisher","first-page":"102681","DOI":"10.1016\/j.xcrm.2026.102681","article-title":"Engineering smart bacteria for the next generation","volume":"7","author":"Qiao","year":"2026","journal-title":"Cell Rep Med"},{"key":"2026091713281185400_iyag235-B110","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1534\/genetics.111.130187","article-title":"Effect of growth under selection on appearance of chromosomal mutations in Salmonella enterica","volume":"189","author":"Qui\u00f1ones-Soto","year":"2011","journal-title":"Genetics"},{"key":"2026091713281185400_iyag235-B111","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","article-title":"Therapeutic in vivo delivery of gene editing agents","volume":"185","author":"Raguram","year":"2022","journal-title":"Cell"},{"key":"2026091713281185400_iyag235-B112","doi-asserted-by":"publisher","first-page":"6116","DOI":"10.1038\/s41467-021-26367-9","article-title":"Intracellular delivery of protein drugs with an autonomously lysing bacterial system reduces tumor growth and metastases","volume":"12","author":"Raman","year":"2021","journal-title":"Nat Commun"},{"key":"2026091713281185400_iyag235-B113","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.chom.2023.09.006","article-title":"Build-a-bug workshop: using microbial-host interactions and synthetic biology tools to create cancer therapies","volume":"31","author":"Raman","year":"2023","journal-title":"Cell Host Microbe"},{"key":"2026091713281185400_iyag235-B114","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ymthe.2024.12.038","article-title":"Controlling intracellular protein delivery, tumor colonization and tissue distribution using flhDC in clinically relevant \u0394sseJ Salmonella","volume":"33","author":"Raman","year":"2025","journal-title":"Mol Ther"},{"key":"2026091713281185400_iyag235-B115","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40425-018-0490-z","article-title":"The motility regulator flhDC drives intracellular accumulation and tumor colonization of Salmonella","volume":"7","author":"Raman","year":"2019","journal-title":"J Immunother Cancer"},{"key":"2026091713281185400_iyag235-B116","doi-asserted-by":"publisher","first-page":"eadk1894","DOI":"10.1126\/sciadv.adk1894","article-title":"Clinical translation of antibody drug conjugate dosing in solid tumors from preclinical mouse data","volume":"10","author":"Rubahamya","year":"2024","journal-title":"Sci Adv"},{"key":"2026091713281185400_iyag235-B117","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41467-018-03232-w","article-title":"Diverse genetic error modes constrain large-scale bio-based production","volume":"9","author":"Rugbjerg","year":"2018","journal-title":"Nat Commun"},{"key":"2026091713281185400_iyag235-B118","doi-asserted-by":"publisher","first-page":"eabe1767","DOI":"10.1126\/sciadv.abe1767","article-title":"Optimized gene expression from bacterial chromosome by high-throughput integration and screening","volume":"7","author":"Saleski","year":"2021","journal-title":"Sci Adv"},{"key":"2026091713281185400_iyag235-B119","author":"Samaranayake","year":"2023"},{"key":"2026091713281185400_iyag235-B120","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1128\/aem.63.12.4877-4882.1997","article-title":"A chloride-inducible gene expression cassette and its use in induced lysis of Lactococcus lactis","volume":"63","author":"Sanders","year":"1997","journal-title":"Appl Environ Microbiol"},{"key":"2026091713281185400_iyag235-B121","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/mutage\/geae002","article-title":"Next-generation therapeutics for rare genetic disorders","volume":"39","author":"Sankar","year":"2024","journal-title":"Mutagenesis"},{"key":"2026091713281185400_iyag235-B122","doi-asserted-by":"publisher","first-page":"1487641","DOI":"10.3389\/fmicb.2024.1487641","article-title":"A comprehensive review of probiotics and human health-current prospective and applications","volume":"15","author":"Sarita","year":"2024","journal-title":"Front Microbiol"},{"key":"2026091713281185400_iyag235-B123","doi-asserted-by":"publisher","DOI":"10.1177\/20420188241294134","article-title":"Multi-target gene therapy AUP1602-C to improve healing and quality of life for diabetic foot ulcer patients: a phase I, open-label, dose-finding study","volume":"15","author":"Schindler","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2026091713281185400_iyag235-B124","doi-asserted-by":"publisher","first-page":"12537","DOI":"10.1073\/pnas.0500558102","article-title":"Molecular basis of listeriolysin O pH dependence","volume":"102","author":"Schuerch","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026091713281185400_iyag235-B125","doi-asserted-by":"publisher","first-page":"1583992","DOI":"10.3389\/fmolb.2025.1583992","article-title":"Engineered exosomes: a promising drug delivery platform with therapeutic potential","volume":"12","author":"Schwarz","year":"2025","journal-title":"Front Mol Biosci"},{"key":"2026091713281185400_iyag235-B126","doi-asserted-by":"publisher","first-page":"2316439","DOI":"10.1080\/21505594.2024.2316439","article-title":"Pathogenicity and virulence of Yersinia","volume":"15","author":"Seabaugh","year":"2024","journal-title":"Virulence"},{"key":"2026091713281185400_iyag235-B127","doi-asserted-by":"publisher","first-page":"eabc1600","DOI":"10.1126\/scitranslmed.abc1600","article-title":"Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice","volume":"14","author":"Selvanesan","year":"2022","journal-title":"Sci Transl Med"},{"key":"2026091713281185400_iyag235-B128","doi-asserted-by":"publisher","first-page":"103942","DOI":"10.1016\/j.drudis.2024.103942","article-title":"New approaches for challenging therapeutic targets","volume":"29","author":"Sharma","year":"2024","journal-title":"Drug Discov Today"},{"key":"2026091713281185400_iyag235-B129","doi-asserted-by":"publisher","first-page":"6438","DOI":"10.3390\/molecules28186438","article-title":"Therapeutic antibodies in medicine","volume":"28","author":"Sharma","year":"2023","journal-title":"Molecules"},{"key":"2026091713281185400_iyag235-B130","doi-asserted-by":"publisher","first-page":"35169","DOI":"10.18632\/oncotarget.9071","article-title":"Solid tumors provide niche-specific conditions that lead to preferential growth of Salmonella","volume":"7","author":"Silva-Valenzuela","year":"2016","journal-title":"Oncotarget"},{"key":"2026091713281185400_iyag235-B131","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/bjc.2014.486","article-title":"Direct incorporation of the NKT-cell activator alpha-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy","volume":"111","author":"Singh","year":"2014","journal-title":"Br J Cancer"},{"key":"2026091713281185400_iyag235-B132","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1172\/JCI118423","article-title":"A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide","volume":"97","author":"Somerville","year":"1996","journal-title":"J Clin Invest"},{"key":"2026091713281185400_iyag235-B133","doi-asserted-by":"publisher","first-page":"6583","DOI":"10.1128\/IAI.67.12.6583-6590.1999","article-title":"Escherichia coli msbB gene as a virulence factor and a therapeutic target","volume":"67","author":"Somerville","year":"1999","journal-title":"Infect Immun"},{"key":"2026091713281185400_iyag235-B134","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12934-017-0669-x","article-title":"A review on Lactococcus lactis: from food to factory","volume":"16","author":"Song","year":"2017","journal-title":"Microb Cell Fact"},{"key":"2026091713281185400_iyag235-B135","doi-asserted-by":"publisher","first-page":"001343","DOI":"10.1099\/mic.0.001343","article-title":"Microbial primer: luxR-LuxI quorum sensing","volume":"169","author":"Soto-Aceves","year":"2023","journal-title":"Microbiology (Reading)"},{"key":"2026091713281185400_iyag235-B136","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1126\/science.289.5483.1352","article-title":"Treatment of murine colitis by Lactococcus lactis secreting interleukin-10","volume":"289","author":"Steidler","year":"2000","journal-title":"Science"},{"key":"2026091713281185400_iyag235-B137","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.molcel.2017.10.033","article-title":"Rational design of evolutionarily stable microbial kill switches","volume":"68","author":"Stirling","year":"2017","journal-title":"Mol Cell"},{"key":"2026091713281185400_iyag235-B138","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/abt\/tbaf014","article-title":"Structure and function of therapeutic antibodies approved by the US FDA in 2024","volume":"8","author":"Strohl","year":"2025","journal-title":"Antib Ther"},{"key":"2026091713281185400_iyag235-B139","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/0092-8674(84)90060-6","article-title":"Multimerization of high copy number plasmids causes instability: CoIE1 encodes a determinant essential for plasmid monomerization and stability","volume":"36","author":"Summers","year":"1984","journal-title":"Cell"},{"key":"2026091713281185400_iyag235-B140","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","article-title":"Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma","volume":"20","author":"Toso","year":"2002","journal-title":"J Clin Oncol"},{"key":"2026091713281185400_iyag235-B141","doi-asserted-by":"publisher","first-page":"v174","DOI":"10.1093\/annonc\/mdx393.041","article-title":"First-in-human phase I study of bacterial RNA interference therapeutic CEQ508 in patients with familial adenomatous polyposis (FAP)","volume":"28","author":"Trieu","year":"2017","journal-title":"Ann Oncol"},{"key":"2026091713281185400_iyag235-B142","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/pharmaceutics18010011","article-title":"A systematic review of advanced drug delivery systems: engineering strategies, barrier penetration, and clinical progress (2016-April 2025)","volume":"18","author":"Uzakova","year":"2025","journal-title":"Pharmaceutics"},{"key":"2026091713281185400_iyag235-B143","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s11095-011-0407-8","article-title":"DNA nuclear targeting sequences for non-viral gene delivery","volume":"28","author":"van Gaal","year":"2011","journal-title":"Pharm Res"},{"key":"2026091713281185400_iyag235-B144","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1038\/s41388-019-0681-1","article-title":"Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma","volume":"38","author":"Vitiello","year":"2019","journal-title":"Oncogene"},{"key":"2026091713281185400_iyag235-B145","doi-asserted-by":"publisher","first-page":"101808","DOI":"10.1016\/j.gendis.2025.101808","article-title":"In vivo gene therapy: a strategy for mutations, degenerations, and tumors","volume":"13","author":"Wang","year":"2026","journal-title":"Genes Dis"},{"key":"2026091713281185400_iyag235-B146","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.biotno.2023.09.001","article-title":"Circular mRNA: a novel therapeutic agent","volume":"4","author":"Wang","year":"2023","journal-title":"Biotechnol Notes"},{"key":"2026091713281185400_iyag235-B147","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.1093\/nar\/gkaa325","article-title":"Synthetic promoter design in Escherichia coli based on a deep generative network","volume":"48","author":"Wang","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2026091713281185400_iyag235-B148","first-page":"69","volume-title":"Genome stability from virus to human application","author":"Williams","year":"2016"},{"key":"2026091713281185400_iyag235-B149","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0300-9084(90)90145-7","article-title":"Phi X174 protein E-mediated lysis of Escherichia coli","volume":"72","author":"Witte","year":"1990","journal-title":"Biochimie"},{"key":"2026091713281185400_iyag235-B150","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1432-1033.1989.tb14661.x","article-title":"Biochemical characterization of phi X174-protein-E-mediated lysis of Escherichia coli","volume":"180","author":"Witte","year":"1989","journal-title":"Eur J Biochem"},{"key":"2026091713281185400_iyag235-B151","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-1-60327-547-7_7","article-title":"In vitro and in vivo gene silencing by TransKingdom RNAi (tkRNAi)","volume":"487","author":"Xiang","year":"2009","journal-title":"Methods Mol Biol"},{"key":"2026091713281185400_iyag235-B152","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41392-023-01589-z","article-title":"Recent advances in targeting the \u201cundruggable\u201d proteins: from drug discovery to clinical trials","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026091713281185400_iyag235-B153","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1002\/bab.2738","article-title":"Genetically engineered Bacteria as a promising therapeutic strategy against cancer: a comprehensive review","volume":"72","author":"Zahedifard","year":"2025","journal-title":"Biotechnol Appl Biochem"},{"key":"2026091713281185400_iyag235-B154","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41392-022-01252-z","article-title":"Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2026091713281185400_iyag235-B155","doi-asserted-by":"publisher","first-page":"7647","DOI":"10.1158\/0008-5472.CAN-06-0716","article-title":"Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice","volume":"66","author":"Zhao","year":"2006","journal-title":"Cancer Res"},{"key":"2026091713281185400_iyag235-B156","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4068\/cmj.2016.52.3.173","article-title":"Targeted cancer therapy using engineered Salmonella typhimurium","volume":"52","author":"Zheng","year":"2016","journal-title":"Chonnam Med J"},{"key":"2026091713281185400_iyag235-B157","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","article-title":"Tumour-targeting bacteria engineered to fight cancer","volume":"18","author":"Zhou","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"2026091713281185400_iyag235-B158","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.cell.2020.01.006","article-title":"Host-specific evolutionary and transmission dynamics shape the functional diversification of Staphylococcus epidermidis in human skin","volume":"180","author":"Zhou","year":"2020","journal-title":"Cell"}],"container-title":["GENETICS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/genetics\/advance-article-pdf\/doi\/10.1093\/genetics\/iyag235\/71191632\/iyag235.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/genetics\/advance-article-pdf\/doi\/10.1093\/genetics\/iyag235\/71191632\/iyag235.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:28:22Z","timestamp":1789666102000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/genetics\/advance-article\/doi\/10.1093\/genetics\/iyag235\/8812663"}},"subtitle":[],"editor":[{"given":"S","family":"Lacefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":158,"URL":"https:\/\/doi.org\/10.1093\/genetics\/iyag235","relation":{},"ISSN":["1943-2631"],"issn-type":[{"value":"1943-2631","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"iyag235"}}